Stay updated on Radiation and Checkpoints in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radiation and Checkpoints in NSCLC Clinical Trial page.

Latest updates to the Radiation and Checkpoints in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.9%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check26 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check55 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check69 days agoChange DetectedThe page has been updated to reflect a new treatment protocol for Non-Small Cell Lung Cancer (NSCLC) patients, including specific dosages and timing for ipilimumab and nivolumab, as well as changes in eligibility criteria and study details. The principal investigator's name and affiliation have also been added.SummaryDifference42%
- Check76 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Radiation and Checkpoints in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation and Checkpoints in NSCLC Clinical Trial page.